Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 4,893 | 6,128 | 4,485 | 3,345 | 3,246 |
| Operating Income | -4,893 | -6,128 | -4,485 | -3,345 | -3,246 |
| Interest Expense | 0 | 0 | 89 | 42 | 84 |
| Other Income | 469 | 998 | -240 | 723 | 269 |
| Pre-tax Income | -4,424 | -5,130 | -4,815 | -2,664 | -3,061 |
| Net Income Continuous | -4,424 | -5,130 | -4,815 | -2,664 | -3,061 |
| Net Income | $-4,424 | $-5,130 | $-4,815 | $-2,664 | $-3,061 |
| EPS Basic Total Ops | -0.04 | -0.05 | -0.04 | -0.02 | -0.04 |
| EPS Basic Continuous Ops | -0.04 | -0.05 | -0.04 | -0.02 | -0.04 |
| EPS Diluted Total Ops | -0.04 | -0.05 | -0.04 | -0.02 | -0.04 |
| EPS Diluted Continuous Ops | -0.04 | -0.05 | -0.04 | -0.02 | -0.04 |
| EPS Diluted Before Non-Recurring Items | -0.04 | -0.04 | -0.04 | N/A | N/A |
| EBITDA(a) | $-4,891 | $-6,126 | $-4,484 | $-3,343 | $-3,162 |